| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cervical Vertebrae | 84 | 2023 | 288 | 14.800 |
Why?
|
| Spinal Fusion | 51 | 2023 | 465 | 8.570 |
Why?
|
| Spinal Diseases | 20 | 2017 | 113 | 4.690 |
Why?
|
| Decompression, Surgical | 17 | 2019 | 129 | 3.540 |
Why?
|
| Diskectomy | 20 | 2022 | 184 | 3.400 |
Why?
|
| Spinal Cord Diseases | 18 | 2020 | 48 | 3.080 |
Why?
|
| Neurosurgical Procedures | 12 | 2020 | 127 | 2.930 |
Why?
|
| Zygapophyseal Joint | 5 | 2019 | 24 | 2.530 |
Why?
|
| Spondylosis | 10 | 2022 | 26 | 2.450 |
Why?
|
| Lordosis | 7 | 2023 | 40 | 2.340 |
Why?
|
| Intervertebral Disc | 14 | 2019 | 123 | 2.320 |
Why?
|
| Postoperative Complications | 19 | 2023 | 932 | 2.300 |
Why?
|
| Spinal Fractures | 13 | 2015 | 44 | 2.190 |
Why?
|
| Humans | 158 | 2023 | 28436 | 2.170 |
Why?
|
| Kyphosis | 6 | 2021 | 21 | 1.920 |
Why?
|
| Lumbar Vertebrae | 11 | 2020 | 384 | 1.890 |
Why?
|
| Radiculopathy | 8 | 2019 | 43 | 1.790 |
Why?
|
| Treatment Outcome | 44 | 2023 | 3615 | 1.740 |
Why?
|
| Neck Pain | 8 | 2019 | 28 | 1.740 |
Why?
|
| Internal Fixators | 6 | 2016 | 36 | 1.600 |
Why?
|
| Male | 83 | 2023 | 15291 | 1.500 |
Why?
|
| Laminectomy | 8 | 2013 | 41 | 1.490 |
Why?
|
| Female | 80 | 2023 | 15730 | 1.440 |
Why?
|
| Spinal Injuries | 8 | 2017 | 24 | 1.330 |
Why?
|
| Middle Aged | 65 | 2022 | 9269 | 1.300 |
Why?
|
| Atlanto-Occipital Joint | 8 | 2020 | 13 | 1.250 |
Why?
|
| Axis, Cervical Vertebra | 6 | 2017 | 9 | 1.230 |
Why?
|
| Magnetic Resonance Imaging | 20 | 2021 | 1143 | 1.200 |
Why?
|
| Adult | 54 | 2023 | 8107 | 1.190 |
Why?
|
| Pseudarthrosis | 2 | 2019 | 9 | 1.150 |
Why?
|
| Neurosurgery | 5 | 2023 | 31 | 1.150 |
Why?
|
| Intervertebral Disc Displacement | 6 | 2016 | 87 | 1.130 |
Why?
|
| Atlanto-Axial Joint | 5 | 2015 | 11 | 1.120 |
Why?
|
| Retrospective Studies | 23 | 2023 | 3612 | 1.120 |
Why?
|
| Intervertebral Disc Degeneration | 7 | 2022 | 79 | 1.110 |
Why?
|
| Arthroplasty | 8 | 2022 | 150 | 1.090 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2017 | 730 | 1.040 |
Why?
|
| Spinal Stenosis | 3 | 2019 | 37 | 1.040 |
Why?
|
| Radiography | 22 | 2019 | 640 | 0.980 |
Why?
|
| Aged | 45 | 2019 | 9277 | 0.950 |
Why?
|
| Biological Products | 2 | 2022 | 45 | 0.950 |
Why?
|
| Bone Screws | 12 | 2014 | 146 | 0.940 |
Why?
|
| Joint Instability | 7 | 2015 | 394 | 0.910 |
Why?
|
| Joint Prosthesis | 4 | 2007 | 89 | 0.900 |
Why?
|
| Ossification, Heterotopic | 2 | 2016 | 36 | 0.840 |
Why?
|
| Thoracic Vertebrae | 5 | 2012 | 92 | 0.830 |
Why?
|
| Arachnoiditis | 1 | 2022 | 3 | 0.820 |
Why?
|
| Meningitis | 1 | 2022 | 9 | 0.810 |
Why?
|
| Osteotomy | 3 | 2017 | 171 | 0.810 |
Why?
|
| Monitoring, Intraoperative | 2 | 2013 | 37 | 0.810 |
Why?
|
| Ligaments | 3 | 2012 | 14 | 0.780 |
Why?
|
| Joint Diseases | 2 | 2019 | 113 | 0.770 |
Why?
|
| Range of Motion, Articular | 8 | 2017 | 704 | 0.770 |
Why?
|
| Arthroplasty, Replacement | 4 | 2005 | 153 | 0.760 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2013 | 46 | 0.760 |
Why?
|
| Total Disc Replacement | 3 | 2017 | 13 | 0.750 |
Why?
|
| Spinal Osteophytosis | 4 | 2005 | 9 | 0.740 |
Why?
|
| Neurosurgeons | 1 | 2020 | 7 | 0.710 |
Why?
|
| Occipital Bone | 3 | 2010 | 7 | 0.710 |
Why?
|
| Spinal Cord Injuries | 3 | 2014 | 38 | 0.700 |
Why?
|
| Disease Management | 2 | 2017 | 113 | 0.660 |
Why?
|
| Intubation, Intratracheal | 6 | 2017 | 99 | 0.640 |
Why?
|
| Neural Tube Defects | 2 | 2011 | 8 | 0.630 |
Why?
|
| Wounds, Nonpenetrating | 3 | 2016 | 7 | 0.610 |
Why?
|
| Spinal Cord Compression | 5 | 2014 | 24 | 0.610 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2014 | 35 | 0.610 |
Why?
|
| Bone Plates | 8 | 2019 | 48 | 0.610 |
Why?
|
| Telemedicine | 1 | 2020 | 121 | 0.600 |
Why?
|
| Cervical Atlas | 3 | 2010 | 4 | 0.600 |
Why?
|
| Multiple Sclerosis | 3 | 2019 | 107 | 0.580 |
Why?
|
| Spinal Curvatures | 1 | 2017 | 14 | 0.580 |
Why?
|
| Immobilization | 6 | 2003 | 14 | 0.570 |
Why?
|
| Odontoid Process | 6 | 2017 | 9 | 0.570 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 41 | 0.520 |
Why?
|
| Brown-Sequard Syndrome | 1 | 2016 | 4 | 0.520 |
Why?
|
| Surgical Wound Infection | 5 | 2012 | 88 | 0.510 |
Why?
|
| Hydrocephalus | 3 | 2010 | 19 | 0.510 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 1216 | 0.500 |
Why?
|
| Prospective Studies | 12 | 2022 | 1809 | 0.490 |
Why?
|
| Aged, 80 and over | 16 | 2019 | 4857 | 0.480 |
Why?
|
| Algorithms | 1 | 2017 | 377 | 0.480 |
Why?
|
| Glioma, Subependymal | 1 | 2014 | 6 | 0.470 |
Why?
|
| Pain Measurement | 7 | 2019 | 472 | 0.470 |
Why?
|
| Movement | 6 | 2012 | 117 | 0.460 |
Why?
|
| Head | 1 | 2014 | 22 | 0.450 |
Why?
|
| Meningomyelocele | 2 | 2011 | 5 | 0.450 |
Why?
|
| Immunocompetence | 1 | 2013 | 6 | 0.440 |
Why?
|
| Coccidioidomycosis | 1 | 2013 | 7 | 0.440 |
Why?
|
| Quadriplegia | 1 | 2013 | 8 | 0.440 |
Why?
|
| Ilium | 2 | 2012 | 28 | 0.440 |
Why?
|
| Transforming Growth Factor beta | 2 | 2013 | 87 | 0.440 |
Why?
|
| Seroma | 1 | 2013 | 4 | 0.440 |
Why?
|
| Kinetics | 1 | 2014 | 194 | 0.440 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 2010 | 7 | 0.430 |
Why?
|
| Tantalum | 1 | 2013 | 26 | 0.430 |
Why?
|
| Inflammation | 1 | 2015 | 284 | 0.410 |
Why?
|
| Time Factors | 10 | 2014 | 1491 | 0.410 |
Why?
|
| Registries | 1 | 2014 | 188 | 0.410 |
Why?
|
| Cadaver | 10 | 2017 | 376 | 0.400 |
Why?
|
| Braces | 4 | 2010 | 23 | 0.400 |
Why?
|
| Disability Evaluation | 6 | 2019 | 289 | 0.400 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2006 | 11 | 0.400 |
Why?
|
| Paralysis | 1 | 2012 | 14 | 0.400 |
Why?
|
| Bone Transplantation | 2 | 2013 | 209 | 0.400 |
Why?
|
| Bacterial Infections | 1 | 2012 | 52 | 0.390 |
Why?
|
| Spina Bifida Occulta | 1 | 2011 | 1 | 0.380 |
Why?
|
| Disease Progression | 2 | 2013 | 717 | 0.380 |
Why?
|
| Meningocele | 1 | 2011 | 4 | 0.380 |
Why?
|
| Sacrum | 1 | 2011 | 24 | 0.370 |
Why?
|
| Adolescent | 13 | 2021 | 2307 | 0.370 |
Why?
|
| Laryngoscopy | 5 | 2017 | 18 | 0.370 |
Why?
|
| Finite Element Analysis | 3 | 2017 | 29 | 0.370 |
Why?
|
| Fractures, Compression | 1 | 2011 | 7 | 0.370 |
Why?
|
| Vertebroplasty | 1 | 2011 | 10 | 0.370 |
Why?
|
| Movement Disorders | 1 | 2012 | 90 | 0.360 |
Why?
|
| Follow-Up Studies | 13 | 2014 | 1859 | 0.360 |
Why?
|
| Motion | 4 | 2016 | 20 | 0.360 |
Why?
|
| Spinal Canal | 3 | 2013 | 8 | 0.350 |
Why?
|
| Equipment Design | 3 | 2007 | 152 | 0.350 |
Why?
|
| Neck | 4 | 2023 | 26 | 0.340 |
Why?
|
| Skull Fracture, Basilar | 1 | 2010 | 1 | 0.340 |
Why?
|
| Skull Base | 2 | 2010 | 33 | 0.340 |
Why?
|
| Burns, Electric | 1 | 2010 | 1 | 0.340 |
Why?
|
| Anti-Bacterial Agents | 2 | 2012 | 383 | 0.340 |
Why?
|
| Craniotomy | 5 | 2010 | 21 | 0.340 |
Why?
|
| Skull | 1 | 2010 | 21 | 0.340 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 29 | 0.330 |
Why?
|
| Achondroplasia | 1 | 2009 | 1 | 0.330 |
Why?
|
| Low Back Pain | 1 | 2011 | 110 | 0.330 |
Why?
|
| Biomechanical Phenomena | 14 | 2016 | 645 | 0.320 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2009 | 3 | 0.320 |
Why?
|
| Osteomyelitis | 1 | 2009 | 20 | 0.310 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 124 | 0.310 |
Why?
|
| Brain Neoplasms | 5 | 2001 | 88 | 0.310 |
Why?
|
| Cerebrospinal Fluid | 2 | 2002 | 10 | 0.300 |
Why?
|
| Child | 10 | 2021 | 1420 | 0.300 |
Why?
|
| Astrocytes | 3 | 2006 | 150 | 0.290 |
Why?
|
| Child, Preschool | 8 | 2021 | 688 | 0.290 |
Why?
|
| Orthopedic Procedures | 1 | 2011 | 312 | 0.290 |
Why?
|
| Fenretinide | 1 | 2007 | 5 | 0.290 |
Why?
|
| ErbB Receptors | 1 | 2007 | 54 | 0.280 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2006 | 15 | 0.270 |
Why?
|
| Evidence-Based Medicine | 4 | 2013 | 196 | 0.270 |
Why?
|
| Staphylococcal Infections | 1 | 2009 | 158 | 0.270 |
Why?
|
| Arthrodesis | 2 | 2004 | 42 | 0.270 |
Why?
|
| Forkhead Transcription Factors | 1 | 2006 | 23 | 0.270 |
Why?
|
| Prostheses and Implants | 4 | 2014 | 161 | 0.260 |
Why?
|
| Brain Edema | 2 | 2004 | 18 | 0.260 |
Why?
|
| Joint Dislocations | 3 | 2020 | 55 | 0.250 |
Why?
|
| Emergency Medical Services | 2 | 2010 | 29 | 0.250 |
Why?
|
| Benzophenones | 2 | 2022 | 27 | 0.250 |
Why?
|
| Polymers | 2 | 2022 | 43 | 0.250 |
Why?
|
| Polyethylene Glycols | 2 | 2022 | 43 | 0.240 |
Why?
|
| Dura Mater | 2 | 2004 | 16 | 0.240 |
Why?
|
| Signal Transduction | 1 | 2007 | 447 | 0.240 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2004 | 6 | 0.230 |
Why?
|
| Cerebral Infarction | 2 | 2004 | 148 | 0.230 |
Why?
|
| Young Adult | 4 | 2016 | 2069 | 0.220 |
Why?
|
| Ossification of Posterior Longitudinal Ligament | 2 | 2013 | 2 | 0.220 |
Why?
|
| Allostasis | 1 | 2023 | 3 | 0.220 |
Why?
|
| Traction | 2 | 2001 | 33 | 0.220 |
Why?
|
| Ligaments, Articular | 3 | 2001 | 110 | 0.220 |
Why?
|
| Forecasting | 2 | 2003 | 103 | 0.210 |
Why?
|
| Task Performance and Analysis | 1 | 2003 | 48 | 0.210 |
Why?
|
| Automobile Driving | 1 | 2003 | 20 | 0.210 |
Why?
|
| Postoperative Period | 4 | 2014 | 331 | 0.210 |
Why?
|
| Fractures, Bone | 3 | 2017 | 75 | 0.210 |
Why?
|
| Aortic Aneurysm | 1 | 2002 | 13 | 0.210 |
Why?
|
| Vascular Surgical Procedures | 1 | 2002 | 26 | 0.200 |
Why?
|
| Iatrogenic Disease | 1 | 2022 | 28 | 0.200 |
Why?
|
| Ketones | 1 | 2022 | 23 | 0.200 |
Why?
|
| Drainage | 1 | 2002 | 50 | 0.200 |
Why?
|
| Cell Survival | 2 | 2006 | 120 | 0.190 |
Why?
|
| Fracture Fixation | 2 | 2017 | 22 | 0.190 |
Why?
|
| Rotation | 4 | 2014 | 137 | 0.190 |
Why?
|
| Allografts | 2 | 2021 | 218 | 0.180 |
Why?
|
| Incidence | 2 | 2019 | 773 | 0.180 |
Why?
|
| Nervous System Diseases | 1 | 2002 | 121 | 0.180 |
Why?
|
| Spinal Cord | 2 | 2013 | 85 | 0.180 |
Why?
|
| Spine | 2 | 2001 | 108 | 0.180 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 39 | 0.170 |
Why?
|
| Rats | 7 | 2007 | 678 | 0.170 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2000 | 21 | 0.170 |
Why?
|
| Infant | 2 | 2021 | 587 | 0.170 |
Why?
|
| Head Movements | 1 | 2000 | 5 | 0.170 |
Why?
|
| United States | 6 | 2017 | 2201 | 0.170 |
Why?
|
| Leukemia, Myeloid | 1 | 2000 | 4 | 0.170 |
Why?
|
| Asymptomatic Diseases | 1 | 2020 | 11 | 0.170 |
Why?
|
| Orthopedic Fixation Devices | 3 | 2001 | 19 | 0.170 |
Why?
|
| Guidelines as Topic | 1 | 2000 | 68 | 0.160 |
Why?
|
| United States Food and Drug Administration | 2 | 2017 | 22 | 0.160 |
Why?
|
| Patient Safety | 1 | 2020 | 54 | 0.160 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 33 | 0.160 |
Why?
|
| Glioma | 3 | 1995 | 20 | 0.160 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 75 | 0.160 |
Why?
|
| Deglutition Disorders | 1 | 2019 | 35 | 0.160 |
Why?
|
| Comorbidity | 2 | 2011 | 500 | 0.150 |
Why?
|
| Fracture Fixation, Internal | 2 | 1997 | 62 | 0.150 |
Why?
|
| Bone Density | 3 | 1997 | 143 | 0.150 |
Why?
|
| Curriculum | 1 | 2000 | 164 | 0.150 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 281 | 0.150 |
Why?
|
| Transplantation, Homologous | 1 | 2019 | 281 | 0.140 |
Why?
|
| Vertebral Artery | 1 | 2017 | 4 | 0.140 |
Why?
|
| Orthotic Devices | 3 | 2009 | 24 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 933 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2017 | 125 | 0.140 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 28 | 0.130 |
Why?
|
| Aorta | 1 | 2016 | 16 | 0.130 |
Why?
|
| Accidental Falls | 2 | 2017 | 114 | 0.130 |
Why?
|
| Spinal Neoplasms | 3 | 2005 | 38 | 0.130 |
Why?
|
| Astrocytoma | 3 | 2006 | 20 | 0.130 |
Why?
|
| Cell Line, Tumor | 2 | 2007 | 249 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2000 | 219 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 2 | 1995 | 119 | 0.130 |
Why?
|
| Intubation | 1 | 2015 | 6 | 0.130 |
Why?
|
| Larynx | 1 | 2015 | 10 | 0.130 |
Why?
|
| Accidents, Traffic | 2 | 1993 | 23 | 0.130 |
Why?
|
| Dinoprost | 1 | 1995 | 1 | 0.130 |
Why?
|
| Neurologic Examination | 3 | 2014 | 114 | 0.130 |
Why?
|
| Collagen | 1 | 2015 | 82 | 0.120 |
Why?
|
| Neurology | 1 | 2016 | 59 | 0.120 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 506 | 0.120 |
Why?
|
| Feasibility Studies | 3 | 2012 | 232 | 0.120 |
Why?
|
| Debridement | 2 | 2012 | 102 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2011 | 330 | 0.120 |
Why?
|
| Animals | 9 | 2007 | 3780 | 0.120 |
Why?
|
| Health Care Costs | 2 | 2013 | 80 | 0.120 |
Why?
|
| Hypertension | 1 | 2016 | 246 | 0.110 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2014 | 1 | 0.110 |
Why?
|
| Glasgow Coma Scale | 1 | 2014 | 9 | 0.110 |
Why?
|
| Medical Errors | 1 | 2014 | 28 | 0.110 |
Why?
|
| Transplantation, Autologous | 2 | 2013 | 169 | 0.110 |
Why?
|
| In Vitro Techniques | 1 | 2014 | 176 | 0.110 |
Why?
|
| Risk Factors | 2 | 2011 | 2408 | 0.110 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 259 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 1995 | 190 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2021 | 1926 | 0.110 |
Why?
|
| Porosity | 1 | 2013 | 61 | 0.110 |
Why?
|
| Air Bags | 1 | 1993 | 1 | 0.110 |
Why?
|
| Radiology | 1 | 2013 | 16 | 0.110 |
Why?
|
| Seat Belts | 1 | 1993 | 5 | 0.100 |
Why?
|
| Botulinum Toxins | 1 | 1992 | 8 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 988 | 0.100 |
Why?
|
| Torticollis | 1 | 1992 | 12 | 0.100 |
Why?
|
| Dystonia | 1 | 1992 | 15 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 36 | 0.100 |
Why?
|
| Certification | 1 | 2013 | 49 | 0.100 |
Why?
|
| Corpus Callosum | 1 | 1992 | 12 | 0.100 |
Why?
|
| Quality of Life | 3 | 2013 | 661 | 0.100 |
Why?
|
| Treatment Failure | 1 | 2013 | 163 | 0.100 |
Why?
|
| Models, Anatomic | 2 | 2013 | 39 | 0.100 |
Why?
|
| Foramen Magnum | 2 | 2010 | 4 | 0.100 |
Why?
|
| Microsurgery | 1 | 2012 | 42 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 517 | 0.100 |
Why?
|
| Intracranial Aneurysm | 1 | 1992 | 39 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 372 | 0.100 |
Why?
|
| Brain Stem | 1 | 1992 | 19 | 0.100 |
Why?
|
| Hematoma, Subdural | 1 | 1991 | 7 | 0.090 |
Why?
|
| Chordoma | 2 | 2005 | 9 | 0.090 |
Why?
|
| Radiosurgery | 2 | 2001 | 38 | 0.090 |
Why?
|
| Spinal Nerve Roots | 1 | 2011 | 15 | 0.090 |
Why?
|
| Anesthesia, General | 1 | 2011 | 28 | 0.090 |
Why?
|
| Brain Diseases | 1 | 1992 | 67 | 0.090 |
Why?
|
| Rats, Inbred F344 | 4 | 2006 | 35 | 0.090 |
Why?
|
| Paresthesia | 1 | 1990 | 2 | 0.090 |
Why?
|
| Neck Injuries | 1 | 1990 | 4 | 0.090 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2010 | 7 | 0.090 |
Why?
|
| Fluoroscopy | 3 | 2016 | 54 | 0.090 |
Why?
|
| External Fixators | 1 | 2010 | 9 | 0.090 |
Why?
|
| Recurrence | 1 | 2011 | 322 | 0.090 |
Why?
|
| Off-Label Use | 1 | 2010 | 6 | 0.080 |
Why?
|
| Skull Base Neoplasms | 2 | 2002 | 19 | 0.080 |
Why?
|
| Pneumonia | 1 | 2010 | 77 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 213 | 0.080 |
Why?
|
| Peritoneovenous Shunt | 1 | 1988 | 1 | 0.080 |
Why?
|
| Length of Stay | 1 | 2010 | 329 | 0.080 |
Why?
|
| Eosinophilia | 1 | 1988 | 37 | 0.080 |
Why?
|
| Pain | 3 | 2010 | 405 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2019 | 79 | 0.070 |
Why?
|
| Technology | 1 | 2007 | 5 | 0.070 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2006 | 5 | 0.070 |
Why?
|
| Free Radicals | 1 | 2006 | 8 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2006 | 12 | 0.070 |
Why?
|
| Curcumin | 1 | 2006 | 5 | 0.070 |
Why?
|
| Flavonoids | 1 | 2006 | 17 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2010 | 677 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 36 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 19 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2006 | 149 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 1986 | 16 | 0.070 |
Why?
|
| Phenylpropanolamine | 1 | 1986 | 1 | 0.070 |
Why?
|
| Laryngoscopes | 2 | 2016 | 5 | 0.060 |
Why?
|
| Ischemic Attack, Transient | 1 | 1986 | 17 | 0.060 |
Why?
|
| Aging | 1 | 2015 | 1550 | 0.060 |
Why?
|
| Cholecystitis | 1 | 1985 | 10 | 0.060 |
Why?
|
| Reference Values | 2 | 2003 | 194 | 0.060 |
Why?
|
| Skull Neoplasms | 1 | 2005 | 2 | 0.060 |
Why?
|
| Reoperation | 3 | 2020 | 917 | 0.060 |
Why?
|
| Nonlinear Dynamics | 1 | 2005 | 13 | 0.060 |
Why?
|
| Back Pain | 1 | 2005 | 62 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2004 | 594 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2004 | 24 | 0.060 |
Why?
|
| Biomarkers | 2 | 2020 | 596 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2004 | 47 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2005 | 43 | 0.060 |
Why?
|
| Models, Biological | 3 | 2001 | 326 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2005 | 498 | 0.050 |
Why?
|
| Plasma Substitutes | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2002 | 2 | 0.050 |
Why?
|
| Aorta, Abdominal | 1 | 2002 | 4 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2002 | 9 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2005 | 185 | 0.050 |
Why?
|
| Skin Transplantation | 1 | 2002 | 13 | 0.050 |
Why?
|
| Cardiovascular Agents | 1 | 2002 | 28 | 0.050 |
Why?
|
| Surgical Flaps | 1 | 2002 | 51 | 0.050 |
Why?
|
| Lumbosacral Region | 1 | 2002 | 59 | 0.050 |
Why?
|
| Arm | 2 | 2014 | 84 | 0.050 |
Why?
|
| Cysts | 2 | 1992 | 18 | 0.050 |
Why?
|
| Fiber Optic Technology | 1 | 2001 | 7 | 0.050 |
Why?
|
| Laryngeal Masks | 1 | 2001 | 5 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2002 | 208 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 1384 | 0.050 |
Why?
|
| Videotape Recording | 1 | 2001 | 29 | 0.050 |
Why?
|
| Epidural Space | 2 | 1998 | 20 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2001 | 76 | 0.050 |
Why?
|
| Tectorial Membrane | 1 | 2020 | 1 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 2 | 2011 | 51 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2000 | 84 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 169 | 0.040 |
Why?
|
| Collagen Type IV | 1 | 2019 | 4 | 0.040 |
Why?
|
| Collagen Type II | 1 | 2019 | 20 | 0.040 |
Why?
|
| Stress, Mechanical | 3 | 2001 | 162 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2000 | 199 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 2 | 2000 | 319 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 362 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 1997 | 654 | 0.040 |
Why?
|
| Medical Illustration | 1 | 1998 | 14 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 2017 | 7 | 0.040 |
Why?
|
| Ribs | 1 | 1998 | 15 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2017 | 11 | 0.040 |
Why?
|
| Medulloblastoma | 1 | 1997 | 7 | 0.040 |
Why?
|
| Cerebellar Neoplasms | 1 | 1997 | 5 | 0.040 |
Why?
|
| Hematoma | 1 | 1998 | 19 | 0.040 |
Why?
|
| Body Height | 1 | 1997 | 36 | 0.040 |
Why?
|
| Lipomatosis | 1 | 1997 | 3 | 0.040 |
Why?
|
| Sciatica | 1 | 1997 | 1 | 0.040 |
Why?
|
| Chymopapain | 1 | 1997 | 5 | 0.040 |
Why?
|
| Phospholipases A | 1 | 1997 | 7 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 825 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 1997 | 45 | 0.030 |
Why?
|
| Age Factors | 2 | 2015 | 781 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2000 | 263 | 0.030 |
Why?
|
| Hospitalization | 1 | 2020 | 323 | 0.030 |
Why?
|
| Materials Testing | 1 | 1997 | 136 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 1997 | 68 | 0.030 |
Why?
|
| Wound Healing | 1 | 1998 | 159 | 0.030 |
Why?
|
| Joints | 1 | 1997 | 69 | 0.030 |
Why?
|
| Supine Position | 1 | 2016 | 21 | 0.030 |
Why?
|
| Manipulation, Spinal | 1 | 2016 | 3 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 1995 | 6 | 0.030 |
Why?
|
| Arachidonic Acids | 1 | 1995 | 8 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 32 | 0.030 |
Why?
|
| F2-Isoprostanes | 1 | 1995 | 7 | 0.030 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 1995 | 4 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 51 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1995 | 42 | 0.030 |
Why?
|
| Acromegaly | 1 | 1995 | 2 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 737 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 1995 | 50 | 0.030 |
Why?
|
| Cell Line | 1 | 1995 | 280 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1995 | 25 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 351 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 1994 | 4 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 1995 | 145 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 1994 | 39 | 0.030 |
Why?
|
| Canada | 1 | 2013 | 51 | 0.030 |
Why?
|
| Anesthesia, Inhalation | 1 | 1993 | 3 | 0.030 |
Why?
|
| Bone Nails | 1 | 1993 | 14 | 0.030 |
Why?
|
| Halothane | 1 | 1993 | 12 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 1993 | 34 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2013 | 81 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2013 | 22 | 0.030 |
Why?
|
| Consensus | 1 | 2013 | 98 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 134 | 0.030 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1992 | 2 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 1992 | 14 | 0.020 |
Why?
|
| Peritoneum | 1 | 1991 | 16 | 0.020 |
Why?
|
| Equipment Failure | 1 | 1991 | 39 | 0.020 |
Why?
|
| Insurance Claim Review | 1 | 2011 | 8 | 0.020 |
Why?
|
| Biopsy | 1 | 1992 | 220 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 1990 | 5 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 1990 | 11 | 0.020 |
Why?
|
| Patient Positioning | 1 | 2011 | 41 | 0.020 |
Why?
|
| Posture | 1 | 2011 | 66 | 0.020 |
Why?
|
| Anesthesiology | 1 | 2011 | 26 | 0.020 |
Why?
|
| Models, Neurological | 1 | 1990 | 25 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2011 | 154 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 358 | 0.020 |
Why?
|
| Cerebral Veins | 1 | 1989 | 6 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2001 | 307 | 0.020 |
Why?
|
| Early Ambulation | 1 | 2008 | 17 | 0.020 |
Why?
|
| Convalescence | 1 | 2008 | 8 | 0.020 |
Why?
|
| Vancomycin | 1 | 1988 | 52 | 0.020 |
Why?
|
| Workers' Compensation | 1 | 2008 | 70 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 328 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2008 | 300 | 0.020 |
Why?
|
| Eye | 1 | 1986 | 8 | 0.020 |
Why?
|
| Brain Injuries | 1 | 1986 | 36 | 0.020 |
Why?
|
| Meningioma | 1 | 2005 | 12 | 0.010 |
Why?
|
| Plasmacytoma | 1 | 2005 | 8 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 2005 | 14 | 0.010 |
Why?
|
| Hypesthesia | 2 | 1995 | 7 | 0.010 |
Why?
|
| Neoplasm Transplantation | 2 | 1994 | 13 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2005 | 120 | 0.010 |
Why?
|
| Acute Disease | 2 | 1997 | 208 | 0.010 |
Why?
|
| Temperature | 1 | 1983 | 66 | 0.010 |
Why?
|
| Macrophages | 1 | 1983 | 108 | 0.010 |
Why?
|
| Taxoids | 1 | 2001 | 10 | 0.010 |
Why?
|
| Carboplatin | 1 | 2001 | 24 | 0.010 |
Why?
|
| Mouth, Edentulous | 1 | 2001 | 4 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2001 | 44 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2001 | 39 | 0.010 |
Why?
|
| MEDLINE | 1 | 2000 | 4 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2001 | 199 | 0.010 |
Why?
|
| Review Literature as Topic | 1 | 2000 | 12 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2001 | 177 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 241 | 0.010 |
Why?
|
| Research Design | 1 | 2001 | 207 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 492 | 0.010 |
Why?
|
| Morbidity | 1 | 1998 | 58 | 0.010 |
Why?
|
| Torque | 1 | 1997 | 24 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 1997 | 4 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1997 | 1 | 0.010 |
Why?
|
| Diet, Reducing | 1 | 1997 | 12 | 0.010 |
Why?
|
| Sciatic Nerve | 1 | 1997 | 25 | 0.010 |
Why?
|
| Body Weight | 1 | 1997 | 144 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1997 | 267 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 1992 | 539 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 553 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1997 | 80 | 0.010 |
Why?
|
| Paraplegia | 1 | 1995 | 6 | 0.010 |
Why?
|
| Electronics | 1 | 1995 | 11 | 0.010 |
Why?
|
| Survival Rate | 1 | 1997 | 356 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1995 | 31 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1995 | 33 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 1995 | 81 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1995 | 16 | 0.010 |
Why?
|
| Tracheostomy | 1 | 1995 | 27 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1995 | 266 | 0.010 |
Why?
|
| Ventilator Weaning | 1 | 1995 | 37 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1995 | 59 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1994 | 30 | 0.010 |
Why?
|
| Encephalocele | 1 | 1994 | 24 | 0.010 |
Why?
|
| Encopresis | 1 | 1993 | 1 | 0.010 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 1993 | 4 | 0.010 |
Why?
|
| Myelography | 1 | 1992 | 8 | 0.010 |
Why?
|
| Rabbits | 1 | 1989 | 185 | 0.000 |
Why?
|
| Brain | 1 | 1994 | 1663 | 0.000 |
Why?
|
| Acetylglucosaminidase | 1 | 1983 | 1 | 0.000 |
Why?
|
| Acid Phosphatase | 1 | 1983 | 3 | 0.000 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 1983 | 2 | 0.000 |
Why?
|
| Salmonella typhimurium | 1 | 1983 | 4 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1983 | 26 | 0.000 |
Why?
|
| Cell Adhesion | 1 | 1983 | 32 | 0.000 |
Why?
|
| Ascitic Fluid | 1 | 1983 | 8 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1983 | 21 | 0.000 |
Why?
|
| Phagocytosis | 1 | 1983 | 44 | 0.000 |
Why?
|
| Cell Movement | 1 | 1983 | 82 | 0.000 |
Why?
|